VIVUS (STU:VIU1) Market Cap : €2.66 Mil (As of Apr. 29, 2024)

View and export this data going back to . Start your Free Trial

What is VIVUS Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). VIVUS's share price for the quarter that ended in Mar. 2020 was €2.98. VIVUS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2020 was 10.65 Mil. Therefore, VIVUS's market cap for the quarter that ended in Mar. 2020 was €31.73 Mil.

VIVUS's quarterly market cap declined from Sep. 2019 (€37.68 Mil) to Dec. 2019 (€23.85 Mil) but then increased from Dec. 2019 (€23.85 Mil) to Mar. 2020 (€31.73 Mil).

VIVUS's annual market cap declined from Dec. 2017 (€45.04 Mil) to Dec. 2018 (€21.27 Mil) but then increased from Dec. 2018 (€21.27 Mil) to Dec. 2019 (€23.85 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. VIVUS's Enterprise Value for Today is €2.66 Mil.

VIVUS Market Cap Historical Data

The historical data trend for VIVUS's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Market Cap Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Market Cap

Get a 7-Day Free Trial

97.81

110.85

45.04

21.27

23.85

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Market Cap	Get a 7-Day Free Trial															39.68	33.95	37.68	23.85	31.73

Competitive Comparison of VIVUS's Market Cap

For the Biotechnology subindustry, VIVUS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIVUS's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's Market Cap distribution charts can be found below:

* The bar in red indicates where VIVUS's Market Cap falls into.

VIVUS Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

VIVUS's Market Cap for the fiscal year that ended in Dec. 2019 is calculated as

Market Cap (A: Dec. 2019 )	=	Share Price (A: Dec. 2019 )	*	Shares Outstanding (EOP) (A: Dec. 2019 )
	=	€2.24	*	10.6489
	=	€23.85

VIVUS's Market Cap for the quarter that ended in Mar. 2020 is calculated as

Market Cap (Q: Mar. 2020 )	=	Share Price (Q: Mar. 2020 )	*	Shares Outstanding (EOP) (Q: Mar. 2020 )
	=	€2.98	*	10.649
	=	€31.73

VIVUS (STU:VIU1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

VIVUS Market Cap Related Terms

Thank you for viewing the detailed overview of VIVUS's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines